Is NIRS Able to Detect Ischemia Following Brain Insult

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
BORET Henry, Direction Centrale du Service de Santé des Armées
ClinicalTrials.gov Identifier:
NCT01556620
First received: March 15, 2012
Last updated: NA
Last verified: March 2012
History: No changes posted
  Purpose

We hypothesize that newly developped NIRS sensor (EQUANOX Advance™, 8004CA, NONIN Medical, USA)is able to detect ischemic events recorded by brain tissue oxygen probe (Licox, Integra Neurosciences, USA) and that values are correlated.


Condition
Brain Trauma
SAH
ICH

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The New 4 Wavelengths EQUANOX NIRS Sensor: Correlation and Detection of Ischemic Episodes. An Observational Comparative Study Versus PtiO2

Further study details as provided by Direction Centrale du Service de Santé des Armées:

Enrollment: 8
Study Start Date: November 2011
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Brain injury (head trauma, SAH, ICH)

Criteria

Inclusion Criteria:

  • Necessity of monitoring by PtiO2 and ICP

Exclusion Criteria:

  • Inability to apply NIRS sensor
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01556620

Locations
France
Sainte Anne Military Teaching Hospital
Toulon, France, 83000
Sponsors and Collaborators
Direction Centrale du Service de Santé des Armées
Investigators
Principal Investigator: Henry BORET, MD Direction Centrale du Service de Santé des Armées
  More Information

No publications provided

Responsible Party: BORET Henry, Médecin en Chef, Direction Centrale du Service de Santé des Armées
ClinicalTrials.gov Identifier: NCT01556620     History of Changes
Other Study ID Numbers: DCSSA
Study First Received: March 15, 2012
Last Updated: March 15, 2012
Health Authority: France: AFSSAPS

Keywords provided by Direction Centrale du Service de Santé des Armées:
PtiO2
NIRS

ClinicalTrials.gov processed this record on October 23, 2014